This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Approval times for clinical trials halved with combined review

Last updated on 23 Feb 2022

Combined review is now in place for all new clinical trials of medicines and combined medicine and device trials. We’ve heard from applicants about the benefits of having a joined up regulatory and ethics review with shorter timelines.

Timelines vary depending on the complexity of the application, but overall are twice as fast as they were in 2018.

With our partner, the Medicines and Healthcare products Regulatory Agency (MHRA), and we will continue working on further service improvements for sponsors and applicants, in response to user feedback.

Read more about combined review.

Back to news & updates

Shape the future of the HRA website.